A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections
Authors:
- Schanaz AlloussiSASchanaz Alloussi
- Günther EggerGEGünther Egger
- Hans-Martin BlümleinHBHans-Martin Blümlein
- Gabriel CozmaGCGabriel Cozma
- Claude C. SchulmanCSClaude C. Schulman
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 47 (4) , 542-548
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001Antimicrobial Agents and Chemotherapy, 2003
- Urinary Tract Infections: What’s New?Journal of Urology, 2002
- An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOmiddle dotSENS ProjectJournal of Antimicrobial Chemotherapy, 2002
- Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studiesInternational Journal of Antimicrobial Agents, 2002
- Recurrent urinary tract infection in womenInternational Journal of Antimicrobial Agents, 2001
- Urinary Tract InfectionAnnals of Epidemiology, 2000
- Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract InfectionClinical Infectious Diseases, 1992
- Immunobiotherapy with Uro‐Vaxom in Recurrent Urinary Tract InfectionBritish Journal of Urology, 1990
- Enhancement of the Humoral Immune Response and Resistance to Bacterial Infection in Mice by the Oral Administration of a Bacterial Immunomodulator (OM-89)Immunopharmacology and Immunotoxicology, 1988
- Treatment of Recurrent Urinary Tract Infections: Efficacy of an Orally Administered Biological Response ModifierUrologia Internationalis, 1986